Brief: Invex Therapeutics Granted European Patent For Exenatide In Hydrocephalus
22/11/2023 01:16
Nov 22 (Reuters) - Invex Therapeutics Ltd IXC.AX :
* INVEX GRANTED EUROPEAN PATENT FOR EXENATIDE IN
HYDROCEPHALUS
Source text for Eikon: ID:nASX2rklvw
Further company coverage: IXC.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Invex Therapeutics
See all newsBrief: Invex Therapeutics Requests Trading Halt
Brief: Invex Therapeutics Says Narelle Warren Resigns As CFO
Brief: Invex Therapeutics' Negotiations Discontinued With Neurological Disease Therapeutics Development Co
Australia's Invex Therapeutics falls as agreement talks fade
Brief: Invex Therapeutics Seeks Trading Halt